Skip to main content

Table 2 Laboratory investigations

From: Cardiovascular complications and predictors of mortality in hospitalized patients with COVID-19: a cross-sectional study from the Indian subcontinent

Parameters

Value

Complete blood count (CBC)

 Hemoglobin (g/dL, mean ± SD)

12.0 ± 4.0

 WBC count (× 103/µL, median, Q1–Q3)

9.00 (6.20–12.50)

 Neutrophil (%, median, Q1–Q3)

77.60 (67.07–88.22)

 Lymphocyte (%, median, Q1–Q3)

11.90 (6.50–19.20)

 Neutrophil/lymphocyte ratio (median, Q1–Q3)

6.50 (3.48–12.68)

 Platelet count (× 103/µL, median, Q1–Q3)

226.50 (163.25–310.75)

 Platelet/lymphocyte ratio (median, Q1–Q3)

220.00 (135.00–365.00)

Serum creatinine (mg/dL, median, Q1–Q3)

0.90 (0.78–1.39)

D-dimer (g/L, median, Q1–Q3)

0.90 (0.40–2.70)

Cardiac Troponin T (ng/mL, median, Q1–Q3)

0.028 (0.009–0.925)

NT-ProBNP (ng/L, median, Q1–Q3)

725 (214–2890)

Serum ferritin (ng/mL, median, Q1–Q3)

506 (208–1095)

Serum LDH (U/L, median, Q1–Q3)

418 (292–605)

  1. LDH lactate dehydrogenase, NT-ProBNP N-terminal pro-brain natriuretic peptide, WBC white blood cell